In February 2026, Ghana’s Narcotics Control Commission (NACOC) announced plans to begin implementing a licensing regime for the cultivation and processing of medical and industrial cannabis, following Parliament’s long-awaited approval of the regulatory and cost framework. After more than five years of delays, diplomatic study tours to Morocco, and mounting frustration from industry players watching business opportunities evaporate, the starting gun for Ghana’s cannabis market has finally been fired.
This should be a moment to celebrate. Ghana’s Narcotics Control Commission Act, passed in 2020 and amended in 2023 after a Supreme Court challenge struck down its cannabis provisions on procedural grounds, created the legal architecture for a regulated cannabis sector. The country has the agricultural land, the climate, and critically, a long-standing relationship with the plant. In the Volta region, cannabis cultivation has been a community livelihood for generations – albeit an illicit one, with schoolchildren reported working on illegal plantations as recently as mid-2025. A functioning legal market, the argument goes, could redirect that existing knowledge and labour into a taxed, regulated, and safer industry.
But six years of delays have not been wasted time for everyone. They have been filled with lobbying, framework-writing, and the quiet construction of a licensing regime that – unless deliberately reformed – looks set to hand Ghana’s cannabis future to those with the deepest pockets.
“Economic potential alone,” warned Nana Kwaku Agyemang, CEO of Hempire Agric Ghana and one of the sector’s most prominent local advocates, “does not guarantee national benefit. The distribution of value depends entirely on who can enter the industry.”
Built for foreign capital
The architecture of Ghana’s licensing regime is, on paper, comprehensive. 11 licence categories exist, covering cultivation, breeding, processing, research, export, and distribution, regulated under Legislative Instrument 2475, passed in 2023. Applicants must demonstrate robust security protocols, product traceability systems, and full compliance with quality assurance standards. These are not unreasonable conditions for a controlled substance. What is less reasonable is the cost of meeting them.
The proposed fee structure starts at USD $9,000 for farms of up to 0.4 hectares and rises to USD $45,000 per hectare for larger operations – with annual regulatory fees set at a further 20% of the base licence on top. Separate fees apply for processing, export, transport, and research licences. Industry estimates, according to Agyemang, suggest that the full cost of establishing a compliant operation may run into hundreds of thousands of dollars before a single plant is harvested.
“For most Ghanaian farmers, cooperatives, and small enterprises,” he commented, “these figures do not represent an opportunity. They represent exclusion by design.”
The fees are denominated in US dollars but payable in Ghanaian cedis at the prevailing exchange rate is a design choice with serious consequences in practice. The cedi has recently experienced repeated and sharp devaluations, meaning the real local-currency cost of a dollar-denominated licence fee can spike dramatically between the time an investor assesses an opportunity and when payment is actually due. That price volatility doesn’t just complicate planning, it effectively prices out smaller domestic operators in ways that the already daunting headline figures don’t fully capture.
Crucially, Ghana had been explicitly advised against precisely this approach. A 2021 research report recommended that licensing fees be flexible and designed to allow local entrepreneurs to establish themselves first, explicitly cautioning Ghana against frameworks like Lesotho’s, where only large corporations could afford fees reaching as high as USD $37,000.
Hidden fees
Previous TalkingDrugs reporting on the fee objections noted they were formally contested before the framework was renegotiated and submitted to Parliament. As of this writing, licensing fees remain undisclosed: Parliament approved the framework, but the specific finalised numbers have yet to be published.
The Chamber of Cannabis Industry Ghana, the sector’s main industry body, acknowledges the problem directly. “Without deliberate inclusion mechanisms,” the Chamber said in an email, “the structure may naturally favour well-capitalised investors with the technical and financial capacity to meet regulatory requirements.” It is a candid and telling admission from an industry organisation.
The Chamber advocates for tiered licensing, cooperative models, and local content requirements, also warning that “high licence fees, stringent security protocols, and compliance costs could present significant barriers for smallholder farmers and emerging local entrepreneurs.”
“If not carefully calibrated, the system risks excluding traditional agricultural communities who would otherwise benefit from crop diversification.” the Chamber wrote.
NACOC has offered reassurances, with its Director of Public Affairs Francis Opoku Amoah telling Asaase Radio that if fees “prove prohibitive,” Parliament could review them. However, there’s no clear amount on how this “prohibitive” amount would be determined.
Who’s it for?
This isn’t the first time this has happened in Africa. Lesotho, the first African country to issue cannabis licences in 2018, saw Canadian corporations – Canopy Growth, Supreme Cannabis, and Aphria – pour tens of millions of dollars into a handful of facilities, acquiring stakes in or outright purchasing the early licence holders, while traditional growers remained largely locked out.
Zimbabwe’s experience offers a partial cautionary tale: its early framework initially proposed high fees that raised similar concerns of local exclusions, though regulators subsequently adjusted them as the sector developed slower than anticipated. Even so, British and South African researchers found that the benefits of reform had flowed primarily to established agribusinesses and large-scale commercial operators, with smallholder farmers still largely shut out. In Uganda, a single company holds the sole licence for cannabis cultivation; there, USD $5 million is a minimum capital requirement for market access.
“Without inclusive entry conditions, Ghana risks becoming a cultivation base for external capital,” Agyemang warned, with local communities providing land and labour while value flows elsewhere. Policy, he argued, “will determine whether Ghana’s cannabis industry becomes locally driven or externally controlled.”
The Chamber put it plainly: “For Ghanaian communities, the true measure of success will be whether the framework enables inclusive participation rather than creating a highly restricted, capital-intensive sector accessible only to multinational actors.”
The devil is in the hemp
Though the laws around cannabis cultivation are changing, NACOC has been explicit: recreational cannabis use remains illegal in Ghana. The 2020 Act did bring meaningful change on personal possession – replacing the mandatory 10-year sentence that existed under the old 1990 Narcotics law with a fine. Civil society welcomed this at the time as a meaningful step toward treating drug use as a public health matter rather than a criminal one. Prison is still a reality for those that fail to pay any fines.
The legal duality is stark: commercial cultivation under licence is now permitted, but personal possession outside defined thresholds remains criminalised. The Chamber acknowledged the consequences directly, noting that this “continues to raise social justice and enforcement concerns.”
Ghana’s cannabis industry future features billion-dollar projection, pharmaceutical investment narratives, and job creation promises. But those still being arrested for having a personal amount of cannabis on them remain fully excluded from the picture.
“When regulatory systems become insulated from the people they are meant to serve,” Agyemang commented, “governance risks descending into performance rather than purpose.”
Meaningful reform
For Ghana, a legal, regulated market, even an imperfect one, is preferable to pure prohibition. Job creation, rural economic development, and research opportunities could be real boons for the nation. And NACOC’s insistence that all licensing be conducted directly, warning against intermediaries claiming to facilitate the process, suggests at least some commitment to transparency.
But reform that serves Ghanaians, not just Ghana’s GDP, would look different. “Cannabis sovereignty,” as Agyemang framed it, “demands that licensing fees and regulatory costs be designed to enable participation rather than restrict it.” That means tiered, affordable entry points accessible to smallholder farmers and cooperatives – an approach recommended back in 2021 by Ghana’s own advisors, yet critically missing from today’s framework. It means grappling seriously with the currency problem: dollar-defined fees to be paid in a devaluing cedi are not a stable foundation for growing a domestic agricultural enterprise. It means a clear timeline for reviewing possession laws, so that the people most harmed by prohibition are not simply abandoned at the base of a newly legalised industry.
“An industry promoted as a national economic opportunity,” Agyemang said, “cannot simultaneously operate as a system that structurally excludes the very citizens it is meant to empower.”
